Please login to the form below

Not currently logged in
Email:
Password:

economics

This page shows the latest economics news and features for those working in and with pharma, biotech and healthcare.

Akcea steals march on Alnylam with NICE approval

Akcea steals march on Alnylam with NICE approval

England’s cost effectiveness watchdog says this has addressed the “uncertainties in the company’s economic model” - but Alnylam’s Onpattro is still awaiting the same green light.

Latest news

More from news
Approximately 5 fully matching, plus 959 partially matching documents found.

Latest Intelligence

  • The Orkambi row explained The Orkambi row explained

    It is also slightly more expensive. That’s a far less favourable proposition in health economic and budget impact terms; Vertex argues that Orkambi will help pave the way for more

  • The Orkambi blame game The Orkambi blame game

    As with the US inquiry, the committee of MPs covered a broad range of topics – some questions trying to get to the nitty-gritty of health economics and NICE procedure to

  • Genomics integration: can the NHS rise to the challenge? Genomics integration: can the NHS rise to the challenge?

    Not only do we have a strong economics case, but genomics allowed for faster diagnosis and more accurate treatments.”.

  • Launch trends 2019 Launch trends 2019

    Successful manufacturers start planning their additional evidence early in clinical development, including health economics endpoints in their phase 2 and 3 clinical trials.

  • Unlocking the potential of science and technology in the UK Unlocking the potential of science and technology in the UK

    In 2015, the government announced regional Science and Innovation Audits (SIAs) in order to foster a new approach to regional economic development. ... In the post-Brexit era, greater collaboration within the UK – a more joined-up approach between

More from intelligence
Approximately 2 fully matching, plus 196 partially matching documents found.

Latest appointments

  • Paris biocluster appoints Stéphane Roques as new chief Paris biocluster appoints Stéphane Roques as new chief

    I am convinced that the convergence of their common interests can shape a new world and be a source of economic and societal value.

  • Claes Buxfeldt joins NDA Claes Buxfeldt joins NDA

    He has represented the payer voice in development programmes including the development of payer evidence strategies, pricing, market access strategy, economic models and clinical programme input.

  • Future Thinking appoints Mohamed Muhsin as UK pharma head Future Thinking appoints Mohamed Muhsin as UK pharma head

    Both Muhsin and Bonrepaux-Caux will be focusing on expanding Future Thinking’s global footprint, technical capabilities and will be leveraging the company’s heritage in primary market research, behavioral economics

  • Vintura appoints Lieven Annemans as an associate partner Vintura appoints Lieven Annemans as an associate partner

    He will advise the consultancy's clients on market access issues. Healthcare and life sciences consultancy firm Vintura has appointed health-economics professor Lieven Annemans as an associate partner after previously ... Bas Amesz, partner at Vintura,

  • VCLS appoints Carole Jones to senior market access role VCLS appoints Carole Jones to senior market access role

    her focus on expanding the company’s market access capabilities, spanning payer strategy, health economics and outcomes research (HEOR), health technology assessment (HTA) and communications support. ... The combination of world class regulatory and

More from appointments
Approximately 0 fully matching, plus 34 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 6 fully matching, plus 124 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Red Health

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics